Yes, losartan and carvedilol can be taken together. This combination is not only safe but commonly prescribed, particularly for heart failure and hard-to-control high blood pressure. The two drugs work through different pathways, and major cardiology guidelines recommend using both an ARB like losartan and a beta-blocker like carvedilol as part of standard treatment for heart failure with reduced pumping ability.
Why These Two Drugs Are Paired
Losartan is an angiotensin receptor blocker (ARB). It relaxes blood vessels by blocking a hormone that causes them to tighten, which lowers blood pressure and reduces strain on the heart. Carvedilol is a beta-blocker that slows the heart rate and prevents the heart from beating too forcefully. It also has some blood-vessel-relaxing properties of its own because it blocks certain receptors in the artery walls.
Because they target two separate systems, the combination covers more ground than either drug alone. Your body controls blood pressure through a hormonal system (which losartan blocks) and a stress-response nervous system (which carvedilol blocks). Animal research has confirmed a long-standing interdependency between these two systems: blocking both simultaneously produces broader blood pressure control than blocking just one. The American Heart Association lists both losartan and carvedilol among the medications commonly prescribed for heart failure and notes that people with heart failure typically need more than one medication, each targeting a different factor.
What the Guidelines Recommend
The 2022 AHA/ACC/HFSA heart failure guidelines give their strongest recommendation (Class 1, Level of Evidence A) for using one of three specific beta-blockers proven to reduce mortality in heart failure with reduced ejection fraction: bisoprolol, carvedilol, or sustained-release metoprolol succinate. The same guidelines give their strongest recommendation for using a renin-angiotensin system inhibitor, which includes ARBs like losartan, to reduce illness and death in that same population. ARBs are specifically recommended when a patient cannot tolerate ACE inhibitors due to cough or swelling.
In clinical trials, carvedilol alone reduced the risk of hospitalization for any reason by 29% and heart failure hospitalizations by 38% compared to placebo. The combined risk of death or hospitalization dropped by 35%. These benefits layer on top of those provided by losartan, which is why guidelines call for both drug classes together rather than choosing one or the other.
The Main Risk: Low Blood Pressure
The most important side effect to watch for when taking both medications is blood pressure dropping too low, especially when you stand up quickly. This is called orthostatic hypotension, defined as a drop of 20 mmHg or more in the upper blood pressure number within three minutes of standing. It can cause dizziness, lightheadedness, or fainting, and raises the risk of falls.
Carvedilol carries a higher risk for this than most beta-blockers because it also relaxes blood vessels through its alpha-blocking activity. A higher incidence of low blood pressure has been reported with carvedilol specifically, particularly after the first dose. Losartan, on the other hand, does not appear to increase this risk on its own and may even improve the body’s ability to adjust blood pressure when changing positions. Still, combining two blood-pressure-lowering drugs means the cumulative effect can be significant, especially early in treatment or after a dose increase.
If you notice dizziness when standing, sitting on the edge of the bed for a minute before getting up can help. Staying well hydrated also makes a difference.
Fatigue and Exercise Tolerance
Fatigue is one of the more common side effects of carvedilol. Because the drug slows your heart rate, your body may feel like it has less energy available, particularly during exercise. Some people also experience weakness, weight gain, or diarrhea. Losartan tends to be better tolerated on its own, but the combination can amplify the tired feeling, at least in the first few weeks as your body adjusts.
For most people, this fatigue improves over time. In heart failure patients, the heart actually becomes more efficient with sustained beta-blocker use, so exercise tolerance often improves after the initial adjustment period even though it may feel worse at first.
Kidney and Potassium Monitoring
Losartan affects the hormonal system that regulates kidney function and potassium levels. When starting or increasing the dose, your doctor will typically check kidney function and potassium within two weeks, then again at 1, 3, 6, and 12 months. The concern is a rise in creatinine (a marker of kidney strain) greater than 30% above your baseline or potassium climbing above safe levels. In practice, this is uncommon: in a large study of patients starting drugs in losartan’s class, only about 1.2% had a significant creatinine rise and 0.4% had dangerously high potassium at their first follow-up test.
Carvedilol does not carry the same kidney or potassium risks on its own, but because both drugs lower blood pressure, reduced blood flow to the kidneys can occasionally affect function. Keeping up with the recommended blood work lets your doctor catch any issues early.
Timing and How to Take Them
Carvedilol is usually taken twice daily, with doses spaced 10 to 12 hours apart. If you’re taking it for heart failure, taking it with food helps reduce dizziness. When first starting carvedilol, your doctor may suggest taking the initial dose at bedtime so any dizziness happens while you’re lying down.
Losartan is typically taken once daily and can be taken with or without food. There is no specific requirement to stagger the two medications, but if dizziness is a problem, taking them at slightly different times of day can help spread out their blood-pressure-lowering effects. Many people take losartan in the morning and split their carvedilol into a morning and evening dose without issues.
Who Should Be Cautious
Carvedilol is poorly tolerated by people with asthma. In one study, only 50% of asthma patients could stay on the drug, compared to 84% of those with chronic obstructive pulmonary disease (COPD). Asthma remains a contraindication to beta-blockers like carvedilol because of the risk of triggering airway tightening. If you have asthma and need both drug classes, your doctor may choose a more lung-friendly beta-blocker or adjust the treatment plan.
People who already experience dizziness when standing, older adults prone to falls, and anyone with borderline low blood pressure should be started on low doses of both medications with gradual increases. The goal is to reach the target doses proven to reduce hospitalizations and death, but getting there slowly minimizes side effects along the way.